Recent Finacing
Recent Raise
Signet Therapeutics leverages an “organoid + AI” platform to develop first-in-class targeted therapies for metastatic solid tumors such as diffuse gastric cancer.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
